Literature DB >> 171063

The tissue culture and morphology of human breast tumor cell line BOT-2.

R E Nordquist, D R Ishmael, C A Lovig, D M Hyder, A F Hoge.   

Abstract

A continuous human breast tumor cell line (BOT-2) was derived from an infiltrating duct carcinoma. The tumor cell line was grown as a monolayer in flasks, but the cells could be readily adapted to growth in roller cultures. These studies indicate that BOT-2 cells have a 16- to 18-hr doubling time and a modal chromosomal number of 63. The original BOT-2 cell culture has been in continuous cultivation for almost 2 years and has been passed 137 times. The BOT-2 cell line has been differentiated from HeLa cells by isoenzyme studies and chromosomal analysis.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 171063

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

1.  Description of a new human breast cancer cell line, IIB-BR-G, established from a primary undifferentiated tumor.

Authors:  L Bover; M Barrio; I Slavutsky; A I Bravo; C Quintans; A Bagnăti; B Lema; J Schiaffi; R Yomha; J Mordoh
Journal:  Breast Cancer Res Treat       Date:  1991-09       Impact factor: 4.872

2.  Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization.

Authors:  R Cailleau; M Olivé; Q V Cruciger
Journal:  In Vitro       Date:  1978-11

3.  Long-term tissue cultures of human pleural effusions: a cytological follow-up.

Authors:  J Mouriquand; C Mouriquand; E Petitpas; M A Mermet
Journal:  In Vitro       Date:  1978-07

Review 4.  Stem cells and the development of mammary cancers in experimental rats and in humans.

Authors:  P S Rudland
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

5.  In vitro cultivation of human renal cell cancer. II. Characterization of cell lines.

Authors:  R D Williams; A Y Elliott; N Stein; E E Fraley
Journal:  In Vitro       Date:  1978-09

6.  Two new estrogen-supersensitive variants of the MCF-7 human breast cancer cell line.

Authors:  C Natoli; G Sica; V Natoli; A Serra; S Iacobelli
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

7.  Establishment and characterization of a new cell line from primary human breast carcinoma.

Authors:  D Amadori; L Bertoni; A Flamigni; S Savini; C De Giovanni; S Casanova; F De Paola; A Amadori; E Giulotto; W Zoli
Journal:  Breast Cancer Res Treat       Date:  1993-12       Impact factor: 4.872

8.  Autologous and homologous immunofluorescent antibody to established breast cancer cell lines.

Authors:  C Wiseman; R Cailleau; M Olivé; G R Blumenschein; J M Bowen
Journal:  In Vitro       Date:  1980-07

9.  A new cell line (8701-BC) from primary ductal infiltrating carcinoma of human breast.

Authors:  S Minafra; V Morello; F Glorioso; A M La Fiura; R M Tomasino; S Feo; D McIntosh; D E Woolley
Journal:  Br J Cancer       Date:  1989-08       Impact factor: 7.640

10.  Establishment of two new cell lines derived from human breast carcinomas with HER-2/neu amplification.

Authors:  P Meltzer; A Leibovitz; W Dalton; H Villar; T Kute; J Davis; R Nagle; J Trent
Journal:  Br J Cancer       Date:  1991-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.